See more : Ionic Brands Corp. (IONC.CN) Income Statement Analysis – Financial Results
Complete financial analysis of WW International, Inc. (WW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of WW International, Inc., a leading company in the Personal Products & Services industry within the Consumer Cyclical sector.
You may be interested
- Zhejiang Fenglong Electric Co., Ltd. (002931.SZ) Income Statement Analysis – Financial Results
- Goliath Resources Limited (GOT.V) Income Statement Analysis – Financial Results
- Central Japan Railway Company (CJPRF) Income Statement Analysis – Financial Results
- Fayenceries de Sarreguemines, Digoin & Vitry-le-Francois Société Anonyme (FAYE.PA) Income Statement Analysis – Financial Results
- Nykredit Invest Danske Aktier Akk KL (NYIDAA.CO) Income Statement Analysis – Financial Results
WW International, Inc. (WW)
About WW International, Inc.
WW International, Inc. provides weight management products and services worldwide. The company operates in four segments: North America, Continental Europe, United Kingdom, and Other. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and Web-based products, including personal coaching and digital products; and allows members to inspire and support each other by sharing their experiences with other people on weight management and wellness journeys. In addition, it offers various consumer products, including bars, snacks, cookbooks, kitchen tools, and other products. Further, the company licenses its trademarks and other intellectual property in food, beverages, and other relevant consumer products and services, as well as provides publishing services. It offers products through e-commerce platforms and through partners. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1961 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 889.55M | 1.04B | 1.21B | 1.38B | 1.41B | 1.51B | 1.31B | 1.16B | 1.16B | 1.48B | 1.72B | 1.83B | 1.82B | 1.45B | 1.40B | 1.54B | 1.47B | 1.23B | 1.15B | 1.02B | 943.93M | 809.64M | 623.87M | 399.57M | 399.57M |
| Cost of Revenue | 360.25M | 418.46M | 486.11M | 600.28M | 626.66M | 647.71M | 614.30M | 579.40M | 590.30M | 677.40M | 723.00M | 758.60M | 772.00M | 661.40M | 671.00M | 700.84M | 653.23M | 557.17M | 520.68M | 487.12M | 440.40M | 370.29M | 286.44M | 201.39M | 201.39M |
| Gross Profit | 529.30M | 622.40M | 726.36M | 777.84M | 786.68M | 866.41M | 692.60M | 585.50M | 574.20M | 802.50M | 1.00B | 1.07B | 1.05B | 790.60M | 727.90M | 834.98M | 813.94M | 676.16M | 630.57M | 537.80M | 503.53M | 439.35M | 337.43M | 198.19M | 198.19M |
| Gross Profit Ratio | 59.50% | 59.80% | 59.91% | 56.44% | 55.66% | 57.22% | 53.00% | 50.26% | 49.31% | 54.23% | 58.07% | 58.47% | 57.56% | 54.45% | 52.03% | 54.37% | 55.48% | 54.82% | 54.77% | 52.47% | 53.34% | 54.27% | 54.09% | 49.60% | 49.60% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 223.72M | 263.84M | 268.61M | 297.29M | 254.70M | 251.11M | 211.20M | 190.30M | 205.00M | 243.00M | 244.70M | 228.50M | 208.50M | 183.20M | 170.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 73.03M | 73.03M | 50.74M | 62.10M |
| Selling & Marketing | 238.39M | 244.78M | 261.46M | 260.73M | 244.00M | 226.32M | 200.80M | 194.40M | 201.00M | 262.30M | 295.60M | 343.50M | 292.40M | 217.10M | 200.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 69.72M | 69.72M | 51.45M | 51.45M |
| SG&A | 503.34M | 508.62M | 530.07M | 558.01M | 498.70M | 477.43M | 412.00M | 384.70M | 406.00M | 505.30M | 540.30M | 572.00M | 500.90M | 400.30M | 371.30M | 409.93M | 378.33M | 296.11M | 328.08M | 231.91M | 187.47M | 142.50M | 142.75M | 102.20M | 113.56M |
| Other Expenses | 3.63M | -1.69M | -1.36M | -349.00K | -1.76M | -2.58M | -500.00K | -1.50M | -2.00M | -3.20M | -600.00K | -2.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.35M | 0.00 |
| Operating Expenses | 506.97M | 508.62M | 530.07M | 558.01M | 498.70M | 477.43M | 412.00M | 384.70M | 406.00M | 505.30M | 540.30M | 572.00M | 500.90M | 400.30M | 371.30M | 409.93M | 378.33M | 296.11M | 328.08M | 231.91M | 187.47M | 142.50M | 142.75M | 110.54M | 113.56M |
| Cost & Expenses | 867.22M | 927.08M | 1.02B | 1.16B | 1.13B | 1.13B | 1.03B | 964.10M | 996.30M | 1.18B | 1.26B | 1.33B | 1.27B | 1.06B | 1.04B | 1.11B | 1.03B | 853.28M | 848.76M | 719.03M | 627.86M | 512.79M | 429.18M | 311.93M | 314.95M |
| Interest Income | 0.00 | 81.14M | 87.91M | 123.31M | 135.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.34M | 0.00 | 0.00 |
| Interest Expense | 95.89M | 81.14M | 87.91M | 123.31M | 135.27M | 142.35M | 112.80M | 115.20M | 121.80M | 123.00M | 103.10M | 83.40M | 59.90M | 76.20M | 66.70M | 86.75M | 108.96M | 49.28M | 25.39M | 27.86M | 133.98M | 0.00 | 83.88M | -31.08M | 5.18M |
| Depreciation & Amortization | 52.47M | 43.80M | 48.55M | 50.68M | 45.02M | 44.06M | 50.88M | 52.63M | 53.17M | 49.23M | 44.90M | 36.64M | 31.00M | 29.01M | 27.88M | 25.96M | 20.75M | 14.88M | 13.70M | 10.24M | 7.14M | 6.05M | 13.24M | 10.40M | 9.29M |
| EBITDA | 74.73M | -244.95M | 266.68M | 336.28M | 333.00M | 433.05M | 331.51M | 253.44M | 243.23M | 360.39M | 473.34M | 544.14M | 578.76M | 423.05M | 386.85M | 449.04M | 456.19M | 394.80M | 302.49M | 316.13M | 316.07M | 296.85M | 210.03M | 87.69M | 80.55M |
| EBITDA Ratio | 8.40% | 14.98% | 16.08% | 19.60% | 20.25% | 25.52% | 21.44% | 17.11% | 14.26% | 19.88% | 26.69% | 27.05% | 30.03% | 26.88% | 25.49% | 29.24% | 31.09% | 32.01% | 27.66% | 30.80% | 39.55% | 39.76% | 35.44% | 21.95% | 20.16% |
| Operating Income | 22.33M | 112.09M | 146.38M | 216.16M | 287.99M | 388.99M | 267.30M | 200.80M | 168.10M | 271.30M | 460.80M | 496.30M | 546.30M | 390.30M | 356.60M | 425.05M | 435.61M | 380.05M | 302.49M | 305.89M | 316.07M | 296.85M | 194.69M | 87.64M | 84.63M |
| Operating Income Ratio | 2.51% | 10.77% | 12.07% | 15.69% | 20.38% | 25.69% | 20.45% | 17.24% | 14.44% | 18.33% | 26.73% | 27.17% | 30.03% | 26.88% | 25.49% | 27.68% | 29.69% | 30.81% | 26.28% | 29.84% | 33.48% | 36.66% | 31.21% | 21.93% | 21.18% |
| Total Other Income/Expenses | -95.97M | -478.89M | -69.40M | -123.66M | -137.03M | -144.92M | -122.23M | -116.68M | -112.44M | -89.59M | -125.39M | -93.84M | -63.24M | -77.17M | -66.49M | -90.70M | -109.12M | -49.41M | -23.18M | -16.34M | -83.84M | -61.35M | -67.72M | -20.73M | -20.73M |
| Income Before Tax | -73.63M | -365.78M | 76.67M | 92.50M | 150.96M | 244.06M | 145.10M | 84.10M | 55.60M | 155.60M | 335.40M | 409.50M | 483.00M | 313.20M | 290.10M | 334.35M | 326.49M | 330.64M | 279.32M | 289.55M | 232.23M | 235.54M | 126.97M | 66.92M | 66.92M |
| Income Before Tax Ratio | -8.28% | -35.14% | 6.32% | 6.71% | 10.68% | 16.12% | 11.10% | 7.22% | 4.77% | 10.51% | 19.45% | 22.42% | 26.55% | 21.57% | 20.74% | 21.77% | 22.25% | 26.81% | 24.26% | 28.25% | 24.60% | 29.09% | 20.35% | 16.75% | 16.75% |
| Income Tax Expense | 38.62M | -114.38M | 9.77M | 17.46M | 31.51M | 20.49M | -18.20M | 16.60M | 22.80M | 58.30M | 130.60M | 156.20M | 178.70M | 120.70M | 115.60M | 132.00M | 125.31M | 120.82M | 104.91M | 94.52M | 88.29M | 91.81M | -23.20M | 28.32M | 28.32M |
| Net Income | -112.26M | -251.40M | 67.13M | 75.08M | 119.62M | 223.75M | 163.50M | 67.70M | 32.90M | 97.40M | 204.70M | 253.30M | 304.90M | 194.20M | 177.30M | 204.33M | 201.18M | 209.83M | 174.40M | 183.08M | 143.94M | 143.69M | 147.19M | 37.76M | 37.76M |
| Net Income Ratio | -12.62% | -24.15% | 5.54% | 5.45% | 8.46% | 14.78% | 12.51% | 5.81% | 2.83% | 6.58% | 11.87% | 13.87% | 16.76% | 13.37% | 12.67% | 13.30% | 13.71% | 17.01% | 15.15% | 17.86% | 15.25% | 17.75% | 23.59% | 9.45% | 9.45% |
| EPS | -1.46 | -3.58 | 0.96 | 1.11 | 1.78 | 3.19 | 2.54 | 1.06 | 0.56 | 2.08 | 3.61 | 4.27 | 4.16 | 2.57 | 2.30 | 2.61 | 2.50 | 2.13 | 1.70 | 1.75 | 1.35 | 1.35 | 1.34 | 0.20 | 0.21 |
| EPS Diluted | -1.46 | -3.58 | 0.95 | 1.07 | 1.72 | 3.19 | 2.40 | 1.03 | 0.56 | 2.08 | 3.60 | 4.23 | 4.11 | 2.56 | 2.30 | 2.60 | 2.48 | 2.11 | 1.67 | 1.71 | 1.31 | 1.31 | 1.31 | 0.20 | 0.21 |
| Weighted Avg Shares Out | 76.68M | 70.32M | 69.64M | 67.85M | 67.19M | 70.12M | 64.33M | 63.74M | 58.37M | 56.61M | 56.14M | 60.29M | 73.34M | 75.66M | 77.00M | 78.25M | 80.58M | 98.72M | 102.75M | 104.70M | 106.62M | 106.25M | 108.68M | 189.00M | 182.21M |
| Weighted Avg Shares Out (Dil) | 76.68M | 70.32M | 70.74M | 70.02M | 69.55M | 70.12M | 68.25M | 65.90M | 58.97M | 56.71M | 56.39M | 60.92M | 74.13M | 75.88M | 77.12M | 78.50M | 81.11M | 99.43M | 104.20M | 106.99M | 109.88M | 109.50M | 111.62M | 189.00M | 182.21M |
WW International (WW) Shows Fast-paced Momentum But Is Still a Bargain Stock
WW International (WW) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced...
WW International Stock Surges 67% in 3 Months: Is it Too Late to Buy?
WW's proven behavioral programs enhance its value proposition for customers seeking comprehensive weight management solutions.
More turnover at the top, but this bull still believes in the Weight Watchers parent
D.A. Davidson reckons WW is a buy as its customers need more than a prescription.
WW International, Inc. Announces CFO Transition
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced the appointment of Felicia DellaFortuna as Chief Financial Officer, effective January 1, 2025. She succeeds Heather Stark, who will remain...
Here's Why WW International (WW) is Poised for a Turnaround After Losing -26.67% in 4 Weeks
The heavy selling pressure might have exhausted for WW International (WW) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock...
The Most Seriously Questionable Advertising Slogans of the Past
24/7 Insights The companies on this list wish they never launched these slogans. Some of these brands are known for their risque marketing. There’s a balance between print and television ads with questionable slogans. Also: Are You On Track to...
WW International, Inc. (WW) Q3 2024 Earnings Call Transcript
WW International, Inc. (NASDAQ:WW ) Q3 2024 Results Conference Call November 6, 2024 8:30 AM ET Company Participants David Helderman - Vice President, Investor Relations Tara Comonte - Interim President & Chief Executive Officer Heather Stark - Chief Financial Officer...
WW International (WW) Beats Q3 Earnings and Revenue Estimates
WW International (WW) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.
WW International, Inc. Schedules Third Quarter 2024 Earnings Conference Call
NEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the third quarter 2024 before market open on Wednesday, November 6, 2024.
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy
WeightWatchers announced on Tuesday that it will offer a compounded version of Novo Nordisk‘s popular weight-loss drug Wegovy as part of its weight-management programs, a move that sent its shares soaring nearly 47%.
Source: https://incomestatements.info
Category: Stock Reports